Triterpenes from As Cytotoxic Agents and Chemosensitizers to Overcome Multidrug Resistance of Cancer Cells
Overview
Authors
Affiliations
The detailed mycochemical analysis of the -hexane extract of led to the isolation of four new lanostane diesters, named pholiols A-D (-), together with an acyclic triterpene, (3,6,10,14,18,22)-2,3,22,23-tetrahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetraene (), ergosterol (), and 3β-hydroxyergosta-7,22-diene (). The isolation was carried out by multistep flash chromatography, and the structures were elucidated using extensive spectroscopic analyses, including 1D and 2D NMR and MS measurements. The isolated metabolites (-) were investigated for cytotoxic activity against Colo205 and Colo320 colon adenocarcinoma and nontumoral MRC-5 cell lines. Among the tested compounds, ergosterol () showed substantial cytotoxic activity against all cell lines with IC values of 4.9 μM (Colo 205), 6.5 μM (Colo 320), and 0.50 μM (MRC) with no tumor cell selectivity. A P-glycoprotein efflux pump modulatory test on resistant Colo320 cells revealed that pholiols A () and B () and linear triterpene polyol have the capacity to inhibit the efflux-pump overexpressed in the cells. Moreover, the drug interactions of triterpenes with doxorubicin were studied by the checkerboard method on Colo 320 cells. Pholiols B () and D () interacted in synergistic and acyclic triterpene in a very strong synergistic manner; the combination index (CI) values at 50% of the growth inhibition dose (ED) were found to be 0.348, 0.660, and 0.082, respectively. Our results indicate that is a promising source for finding new triterpenes with significant chemosensitizing activity on cancer cells.
Similie D, Minda D, Bora L, Kroskins V, Luginina J, Turks M Antioxidants (Basel). 2024; 13(8).
PMID: 39199198 PMC: 11351203. DOI: 10.3390/antiox13080952.
Two new lanostanoid glycosides isolated from a Kenyan polypore .
Chemutai Sum W, Ebada S, Gonkhom D, Decock C, Teponno R, Matasyoh J Beilstein J Org Chem. 2023; 19:1161-1169.
PMID: 37560136 PMC: 10407780. DOI: 10.3762/bjoc.19.84.
Yazdani M, Barta A, Hetenyi A, Berkecz R, Spengler G, Vanyolos A Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678601 PMC: 9862111. DOI: 10.3390/ph16010104.
Braciuliene A, Janulis V, Petrikaite V Pharmaceutics. 2022; 14(12).
PMID: 36559087 PMC: 9781225. DOI: 10.3390/pharmaceutics14122593.